Ads
related to: CRISPR
Search results
Broker Revenue Forecasts For CRISPR Therapeutics AG (NASDAQ:CRSP) Are Surging Higher
Simply Wall St. via Yahoo Finance· 3 hours agoCRISPR Therapeutics AG (NASDAQ:CRSP) shareholders will have a reason to smile today, with the...
Wealthcare Advisory Partners LLC Makes New $244,000 Investment in CRISPR Therapeutics AG...
ETF DAILY NEWS· 7 hours agoWealthcare Advisory Partners LLC acquired a new stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) during the fourth quarter, according to its most recent ...
CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 2.1% After Analyst Downgrade
ETF DAILY NEWS· 13 hours agoCRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) shares dropped 2.1% during trading on Friday after Oppenheimer lowered their price target on the stock from $102.00 ...
We're Interested To See How CRISPR Therapeutics (NASDAQ:CRSP) Uses Its Cash Hoard To Grow
Simply Wall St. via Yahoo Finance· 1 day agoNonetheless, only a fool would ignore the risk that a loss making company burns through its cash too...
CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
Zacks via Yahoo Finance· 2 days agoCRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims...
CRISPR-based gene editing treatment shows promise for rare eye disorder
MedicalNewsToday via AOL· 2 days agoResearchers at Oregon Health & Science University used an experimental CRISPR-based gene editing...
CRISPR Therapeutics AG Reports Q1 2024 Earnings: Misses Analyst Net Income Forecast
GuruFocus.com via Yahoo Finance· 23 hours ago&A Expenses: Dropped to $18.0 million from $22.4 million year-over-year. Collaboration Expense: Rose to $47.0 million, compared to $42.2 million in the first quarter of 2023. On May 8, 2024, ...
CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 5 days agoOn CRISPR Therapeutics' (CRSP) first-quarter 2024 earnings call, investors' focus is likely to be on...
CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 3 days agoCRISPR Therapeutics (CRSP) delivered earnings and revenue surprises of 12.27% and 93.94%,...
The 3 Most Undervalued Biotech Stocks to Buy in May 2024
InvestorPlace· 2 hours agoThe biotech sector holds some of the most promising and popular stocks on the market. With the...